Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:20:32 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:CLABF - CORE ONE LABS INC - https://core1labs.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CLABF - Qnot subscribed0.15782-0.01438-8.40.850.143  0.15782  0.1430.50  0.115913:18:48Dec 0815 min RT 2¢

Recent Trades - All 5 today
Time ETExPriceChangeVolume
13:18:48Q0.14-0.03225
13:18:48Q0.14891-0.023295
10:38:17Q0.15782-0.01438600
10:17:04Q0.15485-0.01735100
10:16:35Q0.143-0.0292100
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2023-12-08 18:56U:CLABFNews ReleaseCore One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market
2023-12-01 19:01U:CLABFNews ReleaseCore One Labs ¢ € ™ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer ¢ € ™s and Parkinson ¢ € ™s, Showing Potential to Outperform Current Treatment Methods
2023-08-04 19:25U:CLABFNews ReleaseCore One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer ¢ € ™s and Parkinson's Disease
2023-08-01 19:55U:CLABFNews ReleaseCore One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
2023-07-28 19:27U:CLABFNews ReleaseCore One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer ¢ € ™s and Parkinson ¢ € ™s Disease
2023-07-11 19:26U:CLABFNews ReleaseCore One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
2023-07-07 17:55U:CLABFNews ReleaseCore One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method
2023-05-05 19:26U:CLABFNews ReleaseCore One in Talks with Multiple Companies to Supply Psilocybin
2023-05-01 20:26U:CLABFNews ReleaseCore One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy
2023-04-21 19:56U:CLABFNews ReleaseCore One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility